GB

Gorrela Balasai

Active Director Director DIN 11538711
DIN 11538711 First appointment Feb 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Gorrela Balasai

Data last updated:

Gorrela Balasai is a Director at Bhasara Academic And Research Studio (Opc) Private Limited (since 2026) and Director at Essara Healthcare Private Limited (since 2026).

DIN 11538711
Primary Designation Director
First Appointment 11 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Jun 20262026Active
Essara Healthcare Private Limited U86909KL2026PTC100824
Director11 Feb 20262026Active

Directorship timeline

Open interactive timeline →
Essara Healthcare Private Limited
Bhasara Academic And Research Studio (Opc) Private Limited
Premium access

Shareholding and investment profile for Gorrela Balasai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gorrela Balasai

Gorrela Balasai currently holds 2 directorships: Bhasara Academic And Research Studio (Opc) Private Limited (Director, since 17 Jun 2026); Essara Healthcare Private Limited (Director, since 11 Feb 2026).

Gorrela Balasai was first appointed on 11 Feb 2026 as Director at Essara Healthcare Private Limited.

The current boards of Gorrela Balasai's companies include Ephraim Joe (Bhasara Academic And Research Studio (Opc) Private Limited), Vishal Kaniyarakkal Karthyarath (Essara Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available